Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-28 5:18 pm Sale | 2025-03-31 | 13G | Halozyme Therapeutics, Inc. HALO | BlackRock Inc. BLK | 16,144,164 13.100% | -2,485,654 (-13.34%) | Filing History |
| 2024-11-12 09:36 am Sale | 2024-09-30 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 3,133,412 2.500% | -3,555,646 (-53.16%) | Filing History |
| 2024-10-17 09:36 am Purchase | 2024-09-30 | 13G | Halozyme Therapeutics, Inc. HALO | STATE STREET CORP STT | 6,635,827 5.200% | 6,635,827 (New Position) | Filing History |
| 2024-02-13 5:06 pm Sale | 2023-12-29 | 13G | Halozyme Therapeutics, Inc. HALO | VANGUARD GROUP INC | 13,259,514 10.040% | -269,116 (-1.99%) | Filing History |
| 2024-02-12 06:19 am Sale | 2023-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 6,689,058 5.100% | -451,895 (-6.33%) | Filing History |
| 2024-02-01 3:51 pm Sale | 2024-02-01 | 13G | Halozyme Therapeutics, Inc. HALO | Invesco Ltd. IVZ | 2,816,427 2.100% | -4,220,524 (-59.98%) | Filing History |
| 2024-01-23 11:52 am Sale | 2023-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | BlackRock Inc. BLK | 18,629,818 14.100% | -566,243 (-2.95%) | Filing History |
| 2023-06-09 2:15 pm Purchase | 2023-05-31 | 13G | Halozyme Therapeutics, Inc. HALO | VANGUARD GROUP INC | 13,528,630 10.270% | 224,783 (+1.69%) | Filing History |
| 2023-02-10 2:11 pm Unchanged | 2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | BlackRock Inc. BLK | 19,196,061 14.200% | 0 (Unchanged) | Filing History |
| 2023-02-10 09:00 am Sale | 2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 7,140,953 5.300% | -2,364,815 (-24.88%) | Filing History |
| 2023-02-09 6:35 pm Purchase | 2023-02-08 | 13G | Halozyme Therapeutics, Inc. HALO | Invesco Ltd. IVZ | 7,036,951 5.200% | 7,036,951 (New Position) | Filing History |
| 2023-02-09 11:22 am Sale | 2022-12-30 | 13G | Halozyme Therapeutics, Inc. HALO | VANGUARD GROUP INC | 13,303,847 9.840% | -238,742 (-1.76%) | Filing History |
| 2023-01-26 08:52 am Purchase | 2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | BlackRock Inc. BLK | 19,196,061 13.600% | 981,990 (+5.39%) | Filing History |
| 2023-01-20 3:00 pm Sale | 2022-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | BlackRock Inc. BLK | 18,214,071 13.600% | -1,225,792 (-6.31%) | Filing History |
| 2022-12-12 3:09 pm Purchase | 2022-11-30 | 13G | Halozyme Therapeutics, Inc. HALO | VANGUARD GROUP INC | 13,542,589 10.020% | 46,676 (+0.35%) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | VANGUARD GROUP INC | 13,495,913 9.590% | 346,210 (+2.63%) | Filing History |
| 2022-02-04 06:15 am Sale | 2021-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | Artisan Partners Limited Partnership | 9,505,768 6.800% | -778,368 (-7.57%) | Filing History |
| 2022-01-28 1:54 pm Purchase | 2021-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | BlackRock Inc. BLK | 19,439,863 13.800% | 958,556 (+5.19%) | Filing History |
| 2021-02-12 5:01 pm Sale | 2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | BB Biotech AG | 3,970,000 2.900% | -3,993,056 (-50.14%) | Filing History |
| 2021-02-10 10:57 am Sale | 2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO | VANGUARD GROUP INC | 13,149,703 9.730% | -873,756 (-6.23%) | Filing History |